Gall Matthew 4
4 · iTeos Therapeutics, Inc. · Filed Nov 19, 2024
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Purchase
Common Stock
2024-11-19$7.73/sh+5,000$38,635→ 65,429 total
4 · iTeos Therapeutics, Inc. · Filed Nov 19, 2024
Common Stock